Additional information
Off-white Powder
20402-62-4
ACI-121009
13-ethyl-10,17-dihydroxy-18,19-dinor-17a-pregn-4-en-20-yn-3-one. (10-hydroxy levonorgestrel)
13-ethyl-10,17-dihydroxy-18,19-dinor-17a-pregn-4-en-20-yn-3-one
255.2-256.5°C
C21H28O3
328.45
Ambient
2-8°C
13-Ethyl-10,17-dihydroxy-18,19-dinor-17a-pregn-4-en-20-yn-3-one; (17a)?-?(±)?-13-Ethyl-?10,?17-?dihydroxy-18,?19-?dinorpregn-?4-?en-?20-?yn-?3-?one; (8S,9S,10S,13S,14S,17S)-13-Ethyl-17-ethynyl-10,17-dihydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one;
Contraceptive






![Ethyl (3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethylsulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate](https://staging.analyticachemie.in/wp-content/uploads/1A06130-150x150.png)


![2-sec-butyl-4-{4-[4-(4-methoxyphenyl)piperazin-1-yl]phenyl}-2H-1,2,4-triazol-3(4H)-one](https://staging.analyticachemie.in/wp-content/uploads/1A06380-150x110.png)
![Abiraterone Isopropyl Ether (25 mg) (3-((3S,8R,9S,10R,13S,14S)-3-isopropoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine; 3beta-Isopropoxy-17-(pyridin-3-yl)androsta-5,16-diene)](https://staging.analyticachemie.in/wp-content/uploads/image-1-150x145.png)